Sun Pharmaceutical Industries Q4 Results Live : profit rise by 33.77% YOY

Sun Pharmaceutical Industries Q4 Results Live : Sun Pharmaceutical Industries declared their Q4 results on 22 May, 2024. The topline increased by 9.63% & the profit increased by 33.77% YoY. As compared to the previous quarter the revenue declined by 3.21% and the profit increased by 5.18%.

The Selling, general & administrative expenses declined by 2.71% q-o-q & increased by 5.5% Y-o-Y.

The operating income was down by 12.06% q-o-q & increased by 17.78% Y-o-Y.

The EPS is ₹11.5 for Q4 which increased by 28.38% Y-o-Y.

Sun Pharmaceutical Industries has delivered 0.78% return in the last 1 week, 27.84% return in last 6 months and 22.22% YTD return.

Currently the Sun Pharmaceutical Industries has a market cap of ₹369329.6 Cr and 52wk high/low of ₹1638.85 & ₹932.6 respectively.

As of 23 May, 2024 out of 31 analysts covering the company, 1 analyst has given Sell rating, 5 analysts have given Hold rating, 12 analysts have given Buy rating &13 analysts have given Strong Buy rating.

The consensus recommendation as on 23 May, 2024 was to Buy.